How to Build a Synthetic Lethality Screen

Not a viability screen with two perturbations: a differential design where the comparison is the experiment.

The Short Answer

Build two screens, not one: the same library in a mutant background and in an isogenic wild-type background. The synthetic lethal hits are the guides depleted in the mutant but not in the wild type.

Coverage, MOI, and readout follow the standard rules for a dropout screen — the difference is that the interaction is defined by the difference between screens, not by depletion in either alone.

Design

ElementRequirement
BackgroundsIsogenic pair differing only in the lesion of interest
LibraryFocused (pathway, druggable set) or genome-wide
ReplicatesTwo to three per background, independent transductions
ReadoutDropout over a defined number of doublings
AnalysisInteraction score per gene, not raw depletion
ValidationIndividual reconstruction of the three arms

The first row is what makes the design interpretable and is the most common failure point: two unrelated lines with the same driver mutation are not an isogenic pair.

Analysis: The Difference Is the Result

A guide that depletes in the mutant background may simply target an essential gene. The synthetic lethal signal is the difference in effect between backgrounds.

Practical points:

  • • Normalize each screen to its own baseline before comparing.
  • • Model the interaction explicitly (for example, a multiplicative model on guide abundance).
  • • Aggregate guides to genes and require consistency across guides.
  • • Control the false discovery rate across genes, not guides.

Reporting a list of genes depleted in the mutant background, without the wild-type comparison, is not a synthetic lethality result.

Controls

  • • Non-targeting guides in both backgrounds.
  • • Known synthetic lethal pairs as positive controls for the analysis pipeline (for example, a PARP–BRCA-type pair if the backgrounds permit).
  • • Known essential genes to confirm the screen detects essentiality at all.
  • • Guide-level consistency within each hit gene.

Validation: Reconstruct the Arms

For each candidate, rebuild the three-arm experiment individually:

  1. Lesion A only — viable.
  2. Target knockout only — viable.
  3. Both — not viable.

Arm 3 alone is a combination effect. Only the comparison across arms establishes interaction, and this is where most screen papers stop short.

Common Failures

SymptomLikely cause
Many genes depleted in both backgroundsGeneral essentiality; interaction score not computed
No hits, positive controls failCoverage or doubling time insufficient
Hits that do not reconstructLibrary quality, or context not isogenic
Interaction only at extreme guide depletionPartial-effect artefact

Need an isogenic screen pair?

EDITGENE builds matched backgrounds for differential screens, with documented baseline proliferation, verified isogenicity, and downstream three-arm reconstruction of candidate pairs.

Tell us the lesion and the library scope. Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

Synthetic lethality is defined relative to a specific pair of contexts; results in one background pair are not transferable to another without testing.

Screen hits require three-arm reconstruction; interaction scores depend on the model used and should be reported with it.

Selected references for further reading

  • • O'Neil NJ, et al. Synthetic lethality and cancer. Nature Reviews Genetics. 2017;18:613–623.
  • • Shen JP, et al. Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. Nature Methods. 2017;14:573–576.
  • • Hart T, et al. Evaluation and design of genome-wide CRISPR/SpCas9 knockout screens. G3. 2017;7:2719–2727.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: